−0.020CAD
−4.57 MCAD
1.07 MCAD
204.35 M
About THERALASE TECHNOLOGIES INC
Sector
Industry
CEO
Roger J. Dumoulin-White
Website
Headquarters
Toronto
Founded
1989
ISIN
CA88337V1004
FIGI
BBG000BDZ9K8
Theralase Technologies, Inc. engages in the design, development, and manufacture of patented laser technology platforms used in bio-stimulative and bio-destructive clinical applications in patients. It operates through the Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT) segments. The ACT segment covers the research and development of photo dynamic compounds (PDCs) for the treatment of cancer. The CLT segment is responsible for the company’s medical laser business, which researches, develops, manufactures, and distributes CLT systems to healthcare practitioners predominantly for the healing of pain. The company was founded by Roger J. Dumoulin-White on August 22, 1989 and is headquartered in Toronto, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of TLT is 0.20 CAD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange THERALASE TECHNOLOGIES INC stocks are traded under the ticker TLT.
THERALASE TECHNOLOGIES INC is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for THERALASE TECHNOLOGIES INC has a max estimate of 0.80 CAD and a min estimate of 0.80 CAD.
THERALASE TECHNOLOGIES INC revenue for the last quarter amounts to 281.00 K CAD despite the estimated figure of 290.00 K CAD. In the next quarter revenue is expected to reach 364.00 K CAD.
Yes, you can track THERALASE TECHNOLOGIES INC financials in yearly and quarterly reports right on TradingView.
Like other stocks, TLT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade THERALASE TECHNOLOGIES INC stock right from TradingView charts — choose your broker and connect to your account.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. THERALASE TECHNOLOGIES INC EBITDA is −4.31 M CAD, and current EBITDA margin is −402.51%. See more stats in THERALASE TECHNOLOGIES INC financial statements.